Sunday, 23 October 2016

GSK seeks U.S. approval for shingles vaccine Shingrix

LONDON (Reuters) - GlaxoSmithKline said on Monday it had filed its shingles vaccine Shingrix for U.S. regulatory approval, bringing the potential blockbuster a step closer to market.


No comments:

Post a Comment